Patricio Arias
Pediatric Gastroenterology · New Orleans, LANPI 1366793374
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (60.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Mirum Pharmaceuticals, Inc. at 36.4% of the total. 2025 is the largest year on record at $43,876, more than ten times the $475 reported in 2019. Among pediatric gastroenterology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $486.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirum Pharmaceuticals, Inc.$33K
- Ipsen Biopharmaceuticals, Inc$32K
- Albireo Pharma, Inc.$24K
- AbbVie$682
- Travere Therapeutics, Inc.$546
- Alcresta Therapeutics, Inc.$234
- plus $788 from 16 others
What the payments were for
- Consulting fees$54,27260%
- Speaking & faculty fees$25,79129%
- Travel & lodging$5,3056%
- Food & beverage$5,1126%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 52 | $32,924 |
| Ipsen Biopharmaceuticals, Inc | 21 | $31,585 |
| Albireo Pharma, Inc. | 11 | $23,732 |
| AbbVie | 34 | $682 |
| Travere Therapeutics, Inc. | 24 | $546 |
| Alcresta Therapeutics, Inc. | 12 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $208 |
| Sanofi | 5 | $115 |
| Amgen(2 entities) | 3 | $66 |
| Novo Nordisk | 2 | $50 |
| AstraZeneca | 3 | $50 |
| Gilead | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Shire North American Group Inc | 2 | $41 |
| Pfizer | 2 | $35 |
| QOL Medical, LLC | 1 | $27 |
| Orphalan Inc | 1 | $23 |
| Pharming Healthcare, Inc. | 1 | $20 |
| Echosens North America, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bylvay$54,989
- Livmarli$31,615
- GATTEX$150
- (820) Cholbam$113
How this compares
$90,492 in reported general payments places this provider in the 95th percentile of 30 pediatric gastroenterology providers in Louisiana.
Other pediatric gastroenterology in New Orleans
- Ryan HimesNew Orleans$114K
- Brian MorrisNew Orleans$3K
- Russell ZwienerNew Orleans$3K
- Amanda GlinkyNew Orleans$2K
- Colleen LeblancNew Orleans$2K
- Darnna BanksNew Orleans$2K
- Matthew GieferNew Orleans$2K
- Michael CarverNew Orleans$1K
- Jasmeet MokhaNew Orleans$691
- Erika SmithNew Orleans$667
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.